Facit | Cancer Breakthroughs Realized
Facit | Cancer Breakthroughs Realized
  • About
    • About FACIT
    • Our Network
    • Leadership
    • Careers
    • Contact
  • Portfolio
  • Funds
    • Funds & Programs Overview
      • Prospects
      • Compass Rose
      • WeSEED
  • Falcons’ Fortunes
    • Event Info & RSVP
    • Pitch Competition – apply
  • News
Normal High
Text Size:

Tag: oncolytic virus

FACIT founded Turnstone Biologics debuts on Nasdaq market

Posted on July 21, 2023 (November 1, 2023) by Ricky
Turnstone Biologics

July 21, 2023 – FACIT congratulates Turnstone Biologics on the announcement of their upsized initial public offering (IPO) and debut on the Nasdaq market.

Read More from FACIT founded Turnstone Biologics debuts on Nasdaq market

Posted in Announcement, FACIT Features, NewsTagged immunotherapy, IPO, nasdaq, oncolytic virus, tumor, Turnstone
  • Privacy Policy
  • Accessibility
  • Terms & Conditions
  • Reporting Improper Activities

FACIT
MaRS Centre
661 University Ave., Suite 510
Toronto, Ontario, Canada M5G 0A3

E: info (at) facit.ca